US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 1,309 | 1,664 | 1,504 | 1,820 | 1,713 |
| Cost of Goods | 522 | 495 | 544 | 567 | 504 |
| Gross Profit | 787 | 1,169 | 960 | 1,253 | 1,209 |
| Operating Expenses | 1,708 | 1,710 | 1,723 | 2,644 | 1,722 |
| Operating Income | -399 | -47 | -219 | -823 | -9 |
| Interest Expense | 394 | 377 | 385 | 441 | 242 |
| Other Income | 120 | -23 | 273 | 20 | 113 |
| Pre-tax Income | -673 | -446 | -331 | -1,245 | -139 |
| Net Income Continuous | -673 | -446 | -331 | -1,245 | -139 |
| Net Income | $-673 | $-446 | $-331 | $-1,245 | $-139 |
| EPS Basic Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| EBITDA(a) | $-318 | $37 | $-135 | $-710 | $113 |